NovaQuest Capital Management, the corporate venturing unit which was spun off from US-based healthcare provider Quintiles Transnational in 2010, has raised $80 million for a new fund, NovaQuest Co- Investment Fund I, LP, according to a regulatory filing on 3 May. Novaquest’s existing fund, NovaQuest Pharma Opportunities Fund III, LP, launched in November 2010, had…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.